Marketing molecular diagnostic products, epigenetics research tools and genomics and clinical research services to customers world-wide.

Company Highlights


The Malaysian Palm Oil Board and Orion Genomics publish in Nature the discovery of the epigenetic cause of fruit mantling, opening the way to the successful propagation of high-yielding elite oil palm lines. "Loss of Karma transposon methylation underlies the mantled somaclonal variant of oil palm," (Ong-Abdullah et al. Nature http://dx.doi.org/10.1038/nature15365).
Science Release Corporate Release


The Malaysian Palm Oil Board and Orion Genomics discover key fruit-color gene in oil palm, indicates fruit ripening (Singh, et al. Nature Communications http://dx.doi.org/10.1038/ncomms5106).
Science Release Corporate Release

Orion Genomics launches clinical diagnostics lab, granted CLIA certification and CAP accreditation.

The Malaysian Palm Oil Board and Orion Genomics discover oil yield gene in oil palm (Singh, et al. Nature http://dx.doi.org/10.1038/nature12356).
Science Release Corporate Release

The Malaysian Palm Oil Board and Orion Genomics publish the oil palm genome sequence (Singh, et al. Nature http://dx.doi.org/10.1038/nature12309).
Science Release Corporate Release

Qiagen to market MethylScreen™ Kits for research use under a non-exclusive license.
Corporate Release

» Press Releases      » More News